Silo Pharma’s $5.75 Million Public Offering and Nasdaq Uplisting

Laura Testa
Tagged:

Sichenzia Ross Ference represented Laidlaw & Company (UK) Ltd. în the transaction while Sheppard Mullin advised Silo Pharma.Silo Pharma, Inc. (Nasdaq: SILO) announced the $5.75 million initial…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here